[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bayer AG – SWOT Framework Analysis

January 2016 | 45 pages | ID: B56DE61AD7BEN
Aruvian's R'search

US$ 110.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Based in Germany, Bayer AG is a leading chemical and pharmaceutical company. The company has presence all over the world and is best known for the following brands:
  • Hoestar
  • Previcur Energy
  • Puma
  • InVigor
  • Aspirin
  • Cipro
  • Mirena
  • Talcid
  • Alka-Seltzer
  • Levitra
The company operates through three segments - Healthcare, Material Science, and Crop Science, and has an established brand image in the markets globally. However, with the ongoing consolidation in the pharma industry, the company might be forced to invest in more mergers and acquisitions in the coming years.

The company’s latest financials are:
  • Revenues of Euro 31,168 million in FY 2009
  • Operating profit of Euro 3,006 million
  • Net profit of Euro 1,359 million
A SWOT Analysis is a strategic planning tool used to evaluate:
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
involved in a project or in a business venture. It involves identifying the internal and external factors that are favorable and unfavorable to achieving that objective.

Aruvian’s R’search analyzes the company Bayer AG in the SWOT Framework Analysis. The report includes the following:
  • Business segment analysis of Bayer AG
  • Major products & services of Bayer AG
  • Profile of the industry Bayer AG operates in
  • Profile of its major competitors – Akzo Nobel N. V., AstraZeneca Plc, Dow Chemical Company, Eastman Chemical Company and Johnson & Johnson
  • SWOT Analysis of Bayer AG
  • Future Perspective of Bayer AG
Aruvian’s R’search’s report Bayer AG – SWOT Framework Analysis has a broad ranging content suitable for industry experts as well as logically initiating the industry beginners.
A. EXECUTIVE SUMMARY

B. PROFILE OF BAYER AG

B.1 Industry Profile
B.2 Corporate Profile
B.3 Business Segment Analysis
B.4 Major Products & Services
B.5 Future Perspective: Bayer AG

C. COMPETITOR PROFILES

C.1 Akzo Nobel N.V.
  C.1.1 Corporate Profile
  C.1.2 Business Segment Analysis
C.2 AstraZeneca PLC
  C.2.1 Corporate Profile
  C.2.2 Business Segment Analysis
C.3 Dow Chemical Company
  C.3.1 Corporate Profile
  C.3.2 Business Segment Analysis
C.4 Johnson & Johnson
  C.4.1 Corporate Profile
  C.4.2 Business Segment Analysis
C.5 Eastman Chemical Company
  C.5.1 Corporate Profile
  C.5.2 Business Segment Analysis

D. SWOT FRAMEWORK ANALYSIS

D.1 Strengths to Build Upon
D.2 Weaknesses to Overcome
D.3 Opportunities to Exploit
D.4 Threats to Overcome

E. GLOSSARY OF TERMS


More Publications